Clinical trial · Observational
Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)
Whole-body Magnetische Resonantie Voor Het Opsporen Van Bot- en Weke Delenmetastasen Bij patiënten Met Een Borstcarcinoom (MetaMaRBo)
NCT01291082CI-TRIAL-00009177METAMARBOunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Prospective MR-imaging study : role of magnetic resonance (MR) and Diffusion weighted imaging (DWI) MR in staging and therapy assessment in breast cancer patients with bone metastases.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Breast cancer patients
- description
- Breast cancer patients
Primary outcomes (1)
- measure
- Validation of whole body diffusion weighted MRI in breastcancer patients
- timeFrame
- 6 months
- description
- whole body MRI will be correlated to the nucleair bone scan and PET-CT
Secondary outcomes (1)
- measure
- Whole body MRI with diffusion weighted imaging is a reliable imaging tool for therapy assessment
- timeFrame
- 12 months
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients with a proven breast cancer (by biopsy or imaging) 2. Bone metastases proven by MR, PET-CT or Bone. Patients with visceral metastases can be included if bone metastases are also present. 3. Patient with an informed consent. Exclusion Criteria: 1. Patients with a single bone metastasis treated by Radiotherapy will be excluded. 2. Patients with contra-indication for MRI: pacemaker, cochlear implant, non MR compatible devices (Baclofenpump). 3. Claustrophobia 4. Patient in a bad general condition.
References
Publications (0)
Data not yet available
No reference posted for this study.